抄録
Purpose: NNK [4-(methylnitrosamino)-1-(3-pyridyle)-1-butanone] is a nicotine-derived nitrosaminoketone contained in tobacco smoke used as a powerful chemical carcinogen for rodent experimental models of pulmonary carcinogenesis. To clarify its carcinogenetic mechanisms, we examined the expression status of 22,625 mouse genes. Methods: The affymetrix GeneChip mouse expression 430 A arrays have been used in CD1-induced mouse lung tumor. The affected genes were analyzed by Ingenuity pathway analysis to investigate functional network and gene ontology. Results: A total of 876 genes were found to be differentially expressed at least twofold between NNK-induced tumors and normal lung tissues, 390 up-regulated and 486 down-regulated in these lesions. The functions with the highest P values were related to cellular growth and proliferation (P = 1.71 × 10-4 to 4.10 × 10-2). In addition, we identified canonical pathways for Wnt/β-catenin signaling (P = 0.0338). Conclusions: These results suggest that application of gene expression profiling may provide an improved strategy for therapeutic targeting of tobacco smoking-induced lung cancer.
本文言語 | 英語 |
---|---|
ページ(範囲) | 107-115 |
ページ数 | 9 |
ジャーナル | Journal of Cancer Research and Clinical Oncology |
巻 | 133 |
号 | 2 |
DOI | |
出版ステータス | 出版済み - 2007/02 |
ASJC Scopus 主題領域
- 腫瘍学
- 癌研究